Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Recruiting · NCT00349830 · Registry updated 2026-02-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy | Neoplasms by Histologic Type, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm | Recruiting | Not stated | 2026-02-10 | NCT00349830 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Stanford University | 620 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Stanford University School of Medicine | Stanford | United States | 46 |